Online Only Articles

Additional trisomies amongst patients with chronic lymphocytic leukemia carrying trisomy 12: the accompanying chromosome makes a difference

Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Sweden
Laboratori de Citogenètica Molecular Servei de Patologia Hospital del Mar, Barcelona, Spain;Grup de Recerca Translacional en Neoplàsies Hematològiques, Cancer Research Program, IMIM-Hospital del Mar, Barcelona, Spain
Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Sweden;Institute of Applied Biosciences, CERTH, Thessaloniki, Greece
Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Sweden
AP-HP, Pitie-Salpetriere Hospital, Department of Hematology, and UPMC Univ Paris 06, UMRS 1138, France
Department of Haematology, Royal Bournemouth Hospital, UK
Central European Institute of Technology, Masaryk University and University Hospital Brno, Czech Republic
Institute of Applied Biosciences, CERTH, Thessaloniki, Greece
Institute of Applied Biosciences, CERTH, Thessaloniki, Greece
Department of Haematology, Royal Bournemouth Hospital, UK
Department of Haematology, Royal Bournemouth Hospital, UK
Hospital Universitari Vall d’Hebron, Barcelona, Spain
Consorcio Hospital General Universitario de Valencia, Spain
Fundación Pública Galega de Medicina Xenómica, Santiago de Compostela, Spain
Institut de Recerca Contra la Leucèmia Josep Carreras (IJC), ICO-Hospital GeransTrias i Pujol, Universitat Autònoma de Barcelona, Badalona, Spain
Hospital Universitario Central de Asturias, Oviedo, Spain
Central European Institute of Technology, Masaryk University and University Hospital Brno, Czech Republic
Institute of Applied Biosciences, CERTH, Thessaloniki, Greece
Department of Haematology, Royal Bournemouth Hospital, UK
Hematology Department and HCT Unit, G. Papanicolaou Hospital, Thessaloniki, Greece
Hematology Department and HCT Unit, G. Papanicolaou Hospital, Thessaloniki, Greece
Cancer Sciences, Faculty of Medicine, University of Southampton, UK
Central European Institute of Technology, Masaryk University and University Hospital Brno, Czech Republic
AP-HP, Pitie-Salpetriere Hospital, Department of Hematology, and UPMC Univ Paris 06, UMRS 1138, France
Hematology Department and HCT Unit, G. Papanicolaou Hospital, Thessaloniki, Greece
Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Sweden
Department of Haematology, Royal Bournemouth Hospital, UK
Laboratori de Citogenètica Molecular Servei de Patologia Hospital del Mar, Barcelona, Spain;Grup de Recerca Translacional en Neoplàsies Hematològiques, Cancer Research Program, IMIM-Hospital del Mar, Barcelona, Spain
Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Sweden;Institute of Applied Biosciences, CERTH, Thessaloniki, Greece
Vol. 101 No. 7 (2016): July, 2016 https://doi.org/10.3324/haematol.2015.140202